01 6ALPHARMA PHARMS
01 68877247
01 6Blank
01 6Y
01 62027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8877247
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22321
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8877247
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22321
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8877247
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22321
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8877247
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22321
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8877247
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22321
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-06-19
Patent Expiration Date : 2027-06-19
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
US Patent Number : 8877247
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22321
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-06-19
